The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells

被引:0
|
作者
Rosenzwajg, M
Camus, S
Guigon, M
Gluckman, JC
机构
[1] Hop La Pitie Salpetriere, CERVI, Immunol Lab, F-75651 Paris 13, France
[2] Fac Med, Ecole Prat Hautes Etud, Lab Biol & Genet Deficits Immunitaires, Paris, France
[3] Fac Med, Ecole Prat Hautes Etud, Lab Immunol Cellulaire, Paris, France
关键词
dendritic cells; differentiation; cytokines; hematopoietic progenitors; cord blood CD34(+) cells;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Culturing cord blood CD34(+) cells with granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor (TNF)-alpha for 12 days, and stem cell factor (SCF) for 5 days, resulted in a 40- +/- 26-fold expansion in cell numbers, with 38 +/- 20% dendritic cells (DCs). Interleukin (IL)-4 and IL-13, which share properties, were examined first. Adding either one to the former baseline condition beginning on day 0 halved cell growth while the percentage of DCs increased to 60-70%, resulting in unchanged DC yields. Delaying use of IL-4 or IL-13 to day 5 led to 25-fold cell expansion with approximately 80% DC, the yield of which was then twofold over that of baseline control cultures, while numbers of other cells decreased. IL-4 and IL-13 had no additive or antagonistic effect on DC generation. The effect of Flt3 ligand (FL), known to enhance proliferation of hematopoietic progenitors induced by other growth factors, was examined next. FL added alone induced DC in the same manner as SCF. Using both FL and SCF throughout the culture period enhanced total cell recovery fourfold above that of baseline control cultures on day 12 compared with greater than or equal to 2.5-fold if either one was stopped on day 5. When both FL and SCF were used for 12 days, DC recovery was fivefold that of control cultures, whereas it was to three-to 3.5-fold when either one was stopped on day 5. A similar trend was noted for CD15(+) cells, and, to a lesser extent, for CD14(+) cells. Finally, using SCF and FL for 12 days, with IL-4 or IL-13 added from day 5 onwards, led to comparably enhanced cell yields relative to control cultures with approximately 60% DC. These data underline the need to use appropriate cytokine combinations and schedules to optimize generation of DCs from CD34(+) progenitors. Associated with GM-CSF and TNF-alpha, IL-4 or IL-13 promotes differentiation and maturation of DCs over other myeloid cells. Under the same baseline conditions, FL appears to potentiate SCF throughout the culture period, inducing proliferation and development of DC as well as of other myeloid cells.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 50 条
  • [1] The influence of interleukin (IL)-4 and IL-13 on human dendritic cell differentiation from CD34+ progenitor cells:: the importance of the source of serum
    Di Nicola, M
    Longoni, P
    Magni, AM
    Gianni, AM
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (02) : 386 - 387
  • [2] IL-4 and IL-13 regulate TLR expression and eosinophil-basophil differentiation of cord blood CD34+ progenitor cells
    Reece P.
    Gauvreau G.M.
    Sehmi R.
    Denburg J.A.
    Allergy, Asthma & Clinical Immunology, 10 (Suppl 2)
  • [3] IL-4 and IL-13 Differentially Regulate TLR-Induced Eosinophil-Basophil Differentiation of Cord Blood CD34+ Progenitor Cells
    Reece, Pia
    Gauvreau, Gail M.
    Sehmi, Roma
    Denburg, Judah A.
    PLOS ONE, 2014, 9 (06):
  • [4] FLT3 ligand promotes the generation of a distinct CD34+ human natural killer cell progenitor that responds to IL-15.
    Yu, H
    Fehniger, TA
    Fuchshuber, P
    Thiel, KS
    Vivier, E
    Carson, WE
    Caligiuri, MA
    BLOOD, 1998, 92 (10) : 367A - 367A
  • [5] IL-4 and IL-13 Differentially Regulate TLR-Induced Eosinophil-Basophil Differentiation Of Cord Blood CD34+Progenitor Cells
    Reece, Pia
    Sehmi, Roma
    Denburg, Judah Aryeh
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB158 - AB158
  • [6] Flt3 ligand promotes the generation of a distinct CD34+ human natural killer cell progenitor that responds to interleukin-15
    Yu, HX
    Fehniger, TA
    Fuchshuber, P
    Thiel, KS
    Vivier, E
    Carson, WE
    Caligiuri, MA
    BLOOD, 1998, 92 (10) : 3647 - 3657
  • [7] Dendritic cell differentiation from hematopoietic CD34+ progenitor cells
    Curti, A
    Fogli, M
    Ratta, M
    Biasco, G
    Tura, S
    Lemoli, RM
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (01): : 49 - 52
  • [8] Functional analysis of dendritic cells generated in vitro from blood monocytes and CD34+ progenitors and in vivo with FLT3 ligand
    Luft, T
    Jefford, M
    Hochrein, H
    Rizkalla, M
    Masterman, KA
    Maliszewski, C
    Shortman, K
    Cebon, J
    Maraskovsky, E
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (04) : 1005 - 1005
  • [9] The FLT3 ligand enhances expansion but not differentiation of human natural killer (nk) cells from CD34(+) hematopoietic progenitor cells (HPCs) when combined with interleukin 15 (IL-15).
    Yu, HX
    Carson, WE
    Caligiuri, MA
    BLOOD, 1996, 88 (10) : 3149 - 3149
  • [10] 4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34+ progenitor cells
    Kim, YJ
    Li, GL
    Broxmeyer, HE
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (06): : 895 - 903